Explore News By Topic


Reliance on ‘YouTube Medicine’ May Be Dangerous for Those Concerned About Prostate Cancer

Original Press Release Issued by: NYU Langone Health NOVEMBER 27, 2018 (9:30AM) The most popular YouTube videos on prostate cancer often offer misleading or biased medical information that poses potential health risks to patients, an analysis of the social media platform shows. Led by researchers at NYU School of Medicine and NYU... Read More


$2.5 Million Gift From The John And Daria Barry Foundation to the Prostate Cancer Foundation Establishes New Precision Oncology Center of Excellence Serving U.S. Veterans at VA’s Manhattan Campus

NEW YORK, NY, November 8, 2018 – Helping to advance revolutionary research in prostate cancer and delivery of precision treatments to U.S. Veterans, the John and Daria Barry Foundation has donated $2.5 million to the Prostate Cancer Foundation (PCF) to establish the John and Daria Barry Precision Oncology Center of... Read More


The Prostate Cancer Foundation Awards $5.5 Million to PCF Challenge Award Recipients to Advance Prostate Cancer Research

LOS ANGELES, Calif., October 30, 2018 – The Prostate Cancer Foundation (PCF) is announcing today that it will be awarding more than $5.5 million in research funding to six new 2018 PCF Challenge Award teams. Funding for the PCF Challenge Award will support international, multi-institutional, cross-disciplinary teams of scientists conducting... Read More


Baylor research team awarded $6.3 million NCI grant to develop tools to better understand disparities in prostate, breast cancers

Original Press Release Issued by: Baylor College of Medicine HOUSTON – (Oct. 3, 2018) – As part of the Beau Biden Cancer Moonshot initiative, the National Cancer Institute has awarded $6.3 million dollars to Dr. Nicholas Mitsiades and a multidisciplinary, collaborative team at Baylor College of Medicine to establish a... Read More


Clovis Oncology Receives Breakthrough Therapy Designation for Rubraca® (rucaparib) for Treatment of BRCA1/2-Mutated Metastatic Castration Resistant Prostate Cancer (mCRPC)

Breakthrough Therapy designation (BTD) granted to Rubraca based on initial data from ongoingTRITON2 Phase 2 study in advanced prostate cancer The data set from the TRITON2 study which supported BTD will be presented at the 2018 ESMO Congress later this month in Munich    BOULDER, Colo. (BUSINESS WIRE) -- October... Read More


MD Anderson Immunologist Jim Allison Awarded Nobel Prize

Original Press Release issued by: MD Anderson News Jim Allison, Ph.D., chair of Immunology and executive director of the Immunotherapy Platform at The University of Texas MD Anderson Cancer Center, today was awarded the 2018 Nobel Prize in Physiology or Medicine for launching an effective new way to attack cancer by treating the immune system... Read More


The Prostate Cancer Foundation Reveals the First National Report About Lack Of Basic Prostate Cancer Understanding in The U.S.

LOS ANGELES, Calif., September 18, 2018 – The Prostate Cancer Foundation (PCF) today released the results of its first national public awareness report about risks, actions and attitudes toward prostate cancer in the PCF 3P Report 2018: Public Perception of Prostate Cancer. The PCF 3P Report indicates that 69% of... Read More

FinditParts Announces First Ever Matching Donation Campaign in Commercial Vehicle Industry to Raise Funds And Awareness for Prostate Cancer Research

LOS ANGELES (Sept. 12, 2018) -- FinditParts, the number one supplier of heavy duty truck and trailer parts online, today pledged its commitment to the Prostate Cancer Foundation’s (PCF) community fundraising initiative, Many vs Cancer, to match 100 percent of donations made through its website beginning in September which is... Read More


The Prostate Cancer Foundation Launches PSA Starring Actor Dax Shepard and First-Ever PCF Pushup Challenge as Part of Its ‘Do Blue’ Campaign to Kick-off Prostate Cancer Awareness Month

LOS ANGELES, Calif., September 4, 2018 – This year marks the 25th anniversary of the Prostate Cancer Foundation’s (PCF) efforts of advancing prostate cancer research. In honor of Prostate Cancer Awareness Month this September, PCF is making it the Prostate Cancer ACTION month to create awareness, spark conversations and raise... Read More


Immunotherapy could offer hope for some men with aggressive prostate cancers

Original Press Release issued by: The Institute of Cancer Research, London Study finds that a subset of men with prostate cancer have ‘mismatch’ DNA repair defects in their tumours These men have very aggressive disease with worse survival on currently available therapies BUT are more likely to benefit from immunotherapy New... Read More